Experience real-time quotes &

news with the most powerful

iPhone application for investors.

Get the FREE DailyFinance iPhone application



  • ANADYS PHARMACEUTICALS INC Analyst Recommendations

  • Analyst Consensus: ANDS

    First Call Consensus Recommendation

    • Strong Buy1
    • Buy2
    • Hold3
    • Sell4
    • Strong Sell5
    Mean Analyst Consensus Recommendation Analysts Reporting
    Current Recommendation 1.636 Buy 11
    30 Days Ago 1.917 Buy 12
    60 Days Ago 2.000 Buy 13
    90 Days Ago 2.154 Buy 13
    120 Days Ago 1.923 Buy 13
  • Analyst Ratings: ANDS

    Brokerage Firm Previous Rating Current Rating Change Date Price Target
    Piper Jaffray Neutral Overweight 11/03/2009
    Wedbush Morgan Neutral 10/21/2009 3.00
    ThinkEquity Accumulate Buy 08/11/2009 4.00
    ThinkEquity Source of Funds Accumulate 07/31/2009 3.00
    ThinkEquity Accumulate Buy 05/11/2009 6.00
    JMP Securities Mkt Outperform 04/24/2009 9.00
    ThinkEquity Buy Accumulate 04/23/2009
    Argus Buy Hold 04/17/2009
    Oppenheimer Outperform 04/14/2009 10.00
    JMP Securities Mkt Outperform 04/03/2009 12.00
    Wedbush Morgan Buy 04/02/2009 9.00
    Leerink Swann Outperform 03/20/2009 8.00
    ThinkEquity Buy 03/16/2009 8.00
    Canaccord Adams Buy 02/09/2009 8.00
    Piper Jaffray Neutral Buy 02/09/2009
    ThinkEquity Buy 01/27/2009 6.00
    Rodman & Renshaw Mkt Outperform 01/26/2009 6.00
    JMP Securities Mkt Outperform 01/20/2009 10.00
    Argus Buy 01/15/2009 7.00
    Merriman Curhan Ford Buy 01/07/2009
    Noble Financial Buy 11/24/2008 4.50
    JMP Securities Mkt Outperform 09/24/2008 6.00
    Susquehanna Financial Positive 05/30/2008 5.00
    Cowen & Co Outperform Neutral 08/30/2007
    Merriman Curhan Ford Neutral 02/07/2007
    Susquehanna Financial Positive 01/24/2007
    Stifel Nicolaus Sell Hold 12/20/2006
    JMP Securities Strong Buy Mkt Perform 06/26/2006
    Montgomery & Co Buy Hold 06/26/2006
    Stifel Nicolaus Buy Sell 06/26/2006